| [1] |
Benezra R, Davis RL, Lockshon D,et. al. The protein id:a negative regulator of helix-loop-helix DNA binding proteins[J]. Cell, 1990,61(1):49-59.
|
| [2] |
Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness[J]. Nat Rev Cancer,2014,14(2):77-91.
|
| [3] |
Teng Y, Li X. The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms[J]. Clin Exp Metastasis,2014,31(3):367-377.
|
| [4] |
Sikder HA, Devlin MK, Dunlap S,et al. Id proteins in cell growth and tumorigenesis[J]. Cancer Cell,2003,3(6):525-530.
|
| [5] |
Janatpour MJ,McMaster MT,Genbacev O,et al. Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration[J]. Development,2000,127(3):549-558.
|
| [6] |
Chen XS, Zhang YH, Cai QY,et al. ID2: a negative transcription factor regulating oligodendroglia differentiation[J]. J Neurosci Res,2012,90(5):925-932.
|
| [7] |
Park HJ, Hong M, Bronson RT,et al. Elevated Id2 expression results in precocious neural stem cell depletion and abnormal brain development[J]. Stem Cells,2013,31(5):1010-1021.
|
| [8] |
Butler DC, Haramizu S, Williamson DL,et al. Phospho-ablated Id2 is growth suppressive and pro-apoptotic in proliferating myoblasts[J].PLoS One,2009,4(7):e6302.
|
| [9] |
Sakata-Goto T, Takahashi K, Kiso H, et al. Id2 controls chondrogenesis acting downstream of BMP signaling during maxillary morphogenesis[J]. Bone,2012,50(1):69-78.
|
| [10] |
Kee BL. E and ID proteins branch out[J]. Nat Rev Immunol,2009,9(3):175-184.
|
| [11] |
Miyazaki M, Miyazaki K, Chen S, et al. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development,thymocyte expansion, and lymphomagenesis[J]. Genes Dev,2015,29(4):409-425.
|
| [12] |
Kim NS, Kim HT, Kwon MC,et al. Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling[J]. Mol Cell Biol,2011,31(23):4775-4788.
|
| [13] |
Nakahiro T, Kurooka H, Mori K, et al. Identification of BMPresponsive elements in the mouse Id2 gene[J]. Biochem Biophys Res Commun,2010,399(3):416-421.
|
| [14] |
Belletti B, Prisco M, Morrione A, et al. Regulation of Id2 gene expression by the IGF-I receptor requires signaling by phosphatidylinositol 3-kinase[J]. J Biol Chem, 2001,276 (17):13 867-13 874.
|
| [15] |
Higgins S, Wong SH, Richner M,et al. Fibroblast growth factor 2 reactivates G1 checkpoint in SK-N-MC cells via regulation of p21,inhibitor of differentiation genes (Id1-3), and epithelium-mesenchyme transition-like events[J]. Endocrinology,2009,150(9):4044-4055.
|
| [16] |
Weigent DA. Regulation of Id2 expression in EL4 T lymphoma cells overexpressing growth hormone[J]. Cell Immunol, 2009, 255(1-2):46-54.
|
| [17] |
Guo L, Lan J, Lin Y, et al. Hypoxia/ischemia up-regulates Id2 expression in neuronal cells in vivo and in vitro[J]. Neurosci Lett,2013,554:88-93.
|
| [18] |
Wang KR, Nemoto T, Yokota Y. RFX1 mediates the serum-induced immediate early response of Id2 gene expression[J]. J Biol Chem,2007,282(36):26 167-26 177.
|
| [19] |
Kurooka H, Nakahiro T, Mori K,et al. BMP signaling is responsible for serum-induced Id2 expression[J]. Biochem Biophys Res Commun,2012,420(2):281-287.
|
| [20] |
Annibali D, Gioia U, Savino M,et al. A new module in neural differentiation control: two microRNAs upregulated by retinoic acid,miR-9 and -103, target the differentiation inhibitor ID2[J]. PLoS One,2012,7(7):e40269.
|
| [21] |
Kurooka H, Yokota Y. Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors[J]. J Biol Chem,2005,280(6):4313-4320.
|
| [22] |
Fajerman I, Schwartz AL, Ciechanover A. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination[J].Biochem Biophys Res Commun,2004,314(2):505-512.
|
| [23] |
Lasorella A, Stegmuller J, Guardavaccaro D,et al. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth[J]. Nature,2006,442(7101):471-474.
|
| [24] |
Williams SA,Maecker HL,French DM,et al. USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma[J]. Cell,2011,146(6):918-930.
|
| [25] |
Florio M, Hernandez MC,Yang HM,et al. Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors[J]. Mol Cell Biol,1998,18(9):5435-5444.
|
| [26] |
Guo L, Yang X, Lin X,et al. Silencing of Id2 attenuates hypoxia/ischemia-induced neuronal injury via inhibition of neuronal apoptosis[J]. Behav Brain Res,2015,292:528-536.
|
| [27] |
Alway SE, Degens H, Krishnamurthy G,et al. Potential role for Id myogenic repressors in apoptosis[J]. Am J Physiol Cell Physiol,2002,283(1):C66-76.
|
| [28] |
Cao Y, Liu X, Zhang W,et al. TGF-beta repression of Id2 induces apoptosis in gut epithelial cells[J]. Oncogene, 2009, 28(8):1089-1098.
|
| [29] |
Hua H, Sarvetnick N. ID2 promotes the expansion and survival of growth-arrested pancreatic beta cells[J]. Endocrine, 2007, 32(3):329-337.
|
| [30] |
Saika S, Ikeda K,Yamanaka O,et al. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-tomesenchymal transition of lens epithelium in mice[J]. Am J Physiol Cell Physiol,2006,290(1):C282-289.
|
| [31] |
Veerasamy M, Phanish M, Dockrell ME. Smad mediated regulation of inhibitor of DNA binding 2 and its role in phenotypic maintenance of human renal proximal tubule epithelial cells[J]. PLoS One, 2013,8(1):e51842.
|
| [32] |
Kondo M, Cubillo E, Tobiume K,et al. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation[J].Cell Death Differ,2004,11(10):1092-1101.
|
| [33] |
Gervasi M, Bianchi-Smiraglia A, Cummings M,et al. JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-β[J]. J Cell Biol,2012,196(5):589-603.
|
| [34] |
Chang C, Yang X, Pursell B,et al. Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4[J]. Mol Cell Biol,2013,33(19):3795-3804.
|
| [35] |
Ling F, Kang B, Sun XH. Id proteins: small molecules, mighty regulators[J]. Curr Top Dev Biol,2014,110:189-216.
|
| [36] |
Nair R,Teo WS,Mittal V,et al. ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities[J]. Mol Ther,2014,22(8):1407-1415.
|
| [37] |
Wang C, Chen Q, Hamajima Y,et al. Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway[J]. Chin J Cancer,2012,31(9):430-439.
|
| [38] |
Trabosh VA, Divito KA, D Aguda B,et al. Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis[J]. Carcinogenesis,2009,30(7):1252-1259.
|
| [39] |
Gray MJ, Dallas NA, Van Buren G,et al. Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver[J].Oncogene,2008,27(57):7192-7200.
|
| [40] |
Luo KL, Luo JH, Yu YP. (-)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix protein[J]. Cancer Sci,2010,101(3):707-712.
|
| [41] |
Ahlqvist K, Saamarthy K, Syed Khaja AS,et al. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer[J]. Oncogene,2013,32(12):1601-1608.
|
| [42] |
Tsunedomi R, Iizuka N, Harada S,et al. Susceptibility of hepatomaderived cells to histone deacetylase inhibitors is associated with ID2 expression[J]. Int J Oncol,2013,42(4):1159-1166.
|
| [43] |
Lasorella A, Rothschild G, Yokota Y,et al. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice[J]. Mol Cell Biol,2005,25(9):3563-3574.
|
| [44] |
Coma S, Amin DN, Shimizu A, et al. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F[J]. Cancer Res,2010,70(9):3823-3832.
|
| [45] |
Stighall M, Manetopoulos C, Axelson H,et al. High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells[J]. Int J Cancer,2005,115(3):403-411.
|
| [46] |
Li K, Yao L, Chen L,et al. ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression[J]. Onco Targets Ther,2014,7:1083-1094.
|
| [47] |
Itahana Y,Singh J,Sumida T,et al. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells[J].Cancer Res,2003,63(21):7098-7105.
|
| [48] |
Appaiah H, Bhat-Nakshatri P, Mehta R,et al. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer [J].Cancer Bio Ther,2014,10(6):600-614.
|
| [49] |
Meng Y,Gu C,Wu Z,et al. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors[J]. BMC Cancer,2009,9:75.
|
| [50] |
Wong MV, Jiang S, Palasingam P,et al. A divalent ion is crucial in the structure and dominant-negative function of ID proteins, a class of helix-loop-helix transcription regulators[J]. PLoS One,2012,7(10):e48591.
|